0.2801

0.28 (-1.58%)

As of Jun 14, 2022

Eloxx Pharmaceuticals, Inc. [ELOX]

Source: 

Company Overview

We are a clinical-stage biopharmaceutical company engaged in the science of ribosome modulation, leveraging both our innovative TURBO-ZM chemistry technology platform and our library of novel aminoglycosides in an effort to develop novel oral small molecule Ribosome Modulating Agents (RMAs) and Eukaryotic Ribosome Selective Glycosides (ERSGs), for the treatment of rare and ultra-rare premature stop codon diseases and ribosomal mutations.

CountryUS
Headquarterswatertownmassachusetts
Phone Number(781) 577-5300
Industryservices-commercial physical & biological research
CEOSumit Aggarwal
Websitewww.eloxxpharma.com

Recent Stories